04:32 PM EDT, 09/09/2024 (MT Newswires) -- Avid Bioservices ( CDMO ) reported a fiscal Q1 net loss Monday of $0.09 per diluted share, wider than a loss of $0.03 a year earlier.

Four analysts polled by Capital IQ expected a per-share loss of $0.06.

Revenue for the quarter ended July 31 was $40.2 million, up from $37.7 million a year earlier.

Analysts surveyed by Capital IQ expected $40.8 million.

The company reiterated its revenue guidance for fiscal 2025 of between $160 million and $168 million.

Analysts polled by Capital IQ expect $162.8 million.

Price: 8.90, Change: -0.05, Percent Change: -0.56